Lieber Sarah B, Nahid Musarrat, Navarro-Millán Iris, Rajan Mangala, Sattui Sebastian E, Reid M Carrington, Mandl Lisa A
Division of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Department of Medicine, Weill Cornell Medicine, 530 East 70th Street, New York, NY, USA.
Clin Rheumatol. 2025 Feb;44(2):661-668. doi: 10.1007/s10067-024-07173-2. Epub 2024 Dec 30.
INTRODUCTION / OBJECTIVES: While presence of concomitant SLE and frailty has been associated with greater emergency department (ED) use than SLE alone in young/mid-aged adults, whether frailty increases ED use in older adults with SLE remains unknown. In a nationally representative United States administrative claims dataset, we investigated the association of frailty duration with use of ED services in the SLE population compared with individuals without systemic rheumatic disease (SRD).
We identified Medicare beneficiaries ≥ 65 years with SLE and matched them (1:4) by age and gender with non-SRD comparators with osteoarthritis. Frailty was determined using a claims-based index and examined each study year (1/2006-9/2015). We used mixed-effect Poisson regression to ascertain the effect of frailty duration exposure on the risk of ED visits in those with SLE and in non-SRD participants, adjusting for covariates.
At baseline (2006), frailty prevalence was similar in participants with SLE (N = 1338; 43.7%) and no SRD (N = 5352; 42.4%) (p = 0.37). Frailty prevalence significantly increased and diverged over time between participants with SLE versus no SRD (67.6% versus 63.7% in 2010 and 83.5% versus 78.1% in 2014) (p < 0.05). As frailty duration increased, risk of ED visits increased in both groups, including after covariate adjustment (SLE: incidence rate ratio [IRR] 1.10, 95% confidence interval [CI] 1.09-1.12; non-SRD: IRR 1.09, 95% CI 1.08-1.10).
In this cohort of older adults, duration of frailty conferred similar increased risk of ED visits among those with and without SLE. This underscores the importance of measuring frailty in older populations with SLE. Key Points • Frailty prevalence was similar at baseline, and increased over time, in participants with SLE and those with no systemic rheumatic disease; however, frailty prevalence increased to a greater extent in those with SLE. • Frailty duration conferred similar increased risk of ED visits among older adults with and without SLE. • This underscores the importance of identifying, preventing, and/or reversing frailty in older populations with SLE and not assuming that SLE alone adequately explains health risks.
引言/目的:虽然在年轻/中年成年人中,同时存在系统性红斑狼疮(SLE)和身体虚弱与比单纯SLE更高的急诊科(ED)就诊率相关,但身体虚弱是否会增加老年SLE患者的ED就诊率仍不清楚。在一个具有全国代表性的美国行政索赔数据集中,我们调查了与无系统性风湿性疾病(SRD)的个体相比,身体虚弱持续时间与SLE人群中ED服务使用之间的关联。
我们确定了年龄≥65岁的患有SLE的医疗保险受益人,并按年龄和性别将他们与患有骨关节炎的非SRD对照者以1:4的比例进行匹配。使用基于索赔的指数确定身体虚弱情况,并对每个研究年份(2006年1月 - 2015年9月)进行检查。我们使用混合效应泊松回归来确定身体虚弱持续时间暴露对SLE患者和非SRD参与者中ED就诊风险的影响,并对协变量进行调整。
在基线时(2006年),患有SLE的参与者(N = 1338;43.7%)和无SRD的参与者(N = 5352;42.4%)的身体虚弱患病率相似(p = 0.37)。随着时间的推移,SLE患者与无SRD患者之间的身体虚弱患病率显著增加且出现差异(2010年分别为67.6%和63.7%,2014年分别为83.5%和78.1%)(p < 0.05)。随着身体虚弱持续时间的增加,两组的ED就诊风险均增加,包括在进行协变量调整后(SLE:发病率比[IRR] 1.10,95%置信区间[CI] 1.09 - 1.12;非SRD:IRR 1.09,95% CI 1.08 - 1.10)。
在这个老年人群队列中,身体虚弱持续时间在患有和未患有SLE的人群中赋予了相似的ED就诊风险增加。这强调了在老年SLE人群中测量身体虚弱的重要性。要点 • 在患有SLE和无系统性风湿性疾病的参与者中,基线时身体虚弱患病率相似,且随时间增加;然而,SLE患者的身体虚弱患病率增加幅度更大。 • 身体虚弱持续时间在患有和未患有SLE的老年人中赋予了相似的ED就诊风险增加。 • 这强调了在老年SLE人群中识别、预防和/或逆转身体虚弱的重要性,而不是假设仅SLE就能充分解释健康风险。